Publications by authors named "Adam Gaweda"

Claim this Profile
L
Leveraging quantitative systems pharmacology and artificial intelligence to advance treatment of chronic kidney disease mineral bone disorder.
Adam Gaweda, Michael Brier, Eleanor Lederer

Am J Physiol Renal Physiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of artificial intelligence to chronic kidney disease mineral bone disorder.
Eleanor D Lederer, Mahmoud M Sobh, Michael E Brier, Adam E Gaweda

Clin Kidney J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-guided precision treatment of chronic kidney disease-mineral bone disorder.
Adam E Gaweda, Eleanor D Lederer, Michael E Brier

CPT Pharmacometrics Syst Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Artificial Intelligence to Identify New Mechanisms and Approaches to Therapy of Bone Disorders Associated With Chronic Kidney Disease.
Adam E Gaweda, Eleanor D Lederer, Michael E Brier

Front Med (Lausanne)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox States of Protein Cysteines in Pathways of Protein Turnover and Cytoskeleton Dynamics Are Changed with Aging and Reversed by Slc7a11 Restoration in Mouse Lung Fibroblasts.
Yuxuan Zheng, Michael L Merchant, Tom J Burke, Jeffrey D Ritzenthaler, Ming Li, Adam E Gaweda

Oxid Med Cell Longev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a quantitative systems pharmacology model of chronic kidney disease: metabolic bone disorder.
Adam E Gaweda, Devin E McBride, Eleanor D Lederer, Michael E Brier

Am J Physiol Renal Physiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Proteomics.
Shipra Agrawal, Michael L Merchant, Jiro Kino, Ming Li, Daniel W Wilkey, Adam E Gaweda

Kidney Int Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized anemia management in a dialysis facility - long-term utility as a single-center quality improvement experience
.
Adam E Gaweda, Alfred A Jacobs, George R Aronoff, Michael E Brier

Clin Nephrol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Anemia Management and Precision Medicine in ESA and Iron Pharmacology in End-Stage Kidney Disease.
Michael E Brier, Adam E Gaweda, George R Aronoff

Semin Nephrol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized drug dosing using RBF-Galerkin method: Case of anemia management in chronic kidney disease.
Hossein Mirinejad, Adam E Gaweda, Michael E Brier, Jacek M Zurada, Tamer Inanc

Comput Methods Programs Biomed· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Markers of iron status in chronic kidney disease.
Adam E Gaweda

Hemodial Int· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence for optimal anemia management in end-stage renal disease.
Michael E Brier, Adam E Gaweda

Kidney Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Na+/H+ exchanger regulatory factor 1 in forward trafficking of the type IIa Na+-Pi cotransporter.
Corey J Ketchem, Syed J Khundmiri, Adam E Gaweda, Rebecca Murray, Barbara J Clark

Am J Physiol Renal Physiol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron dosing in kidney disease: inconsistency of evidence and clinical practice.
Adam E Gaweda, Yelena Z Ginzburg, Yossi Chait, Michael J Germain, George R Aronoff

Nephrol Dial Transplant· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplified Warfarin Dose-response Pharmacodynamic Models.
Seongho Kim, Adam E Gaweda, Dongfeng Wu, Lang Li, Shesh N Rai

Biomed Eng (Singapore)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized model discovery: the case of anemia patients.
Elom Akabua, Tamer Inanc, Adam Gaweda, Michael E Brier, Seongho Kim

Comput Methods Programs Biomed· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing ESA and iron therapy in a prospective payment environment.
George R Aronoff, Adam E Gaweda

Nephrol News Issues· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients.
Adam E Gaweda, Premila Bhat, Gregory A Maglinte, Chun-Lan Chang, Jerrold Hill

Hemodial Int· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized anemia management reduces hemoglobin variability in hemodialysis patients.
Adam E Gaweda, George R Aronoff, Alfred A Jacobs, Shesh N Rai, Michael E Brier

J Am Soc Nephrol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reticulocyte-based estimation of red blood cell lifespan.
Wojciech Krzyzanski, Michael E Brier, Timothy M Creed, Adam E Gaweda

Exp Hematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive modeling for improved anemia management in dialysis patients.
Michael E Brier, Adam E Gaweda

Curr Opin Nephrol Hypertens· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.
Michael L Merchant, Adam E Gaweda, Andrew J Dailey, Daniel W Wilkey, Xiaolan Zhang

Kidney Int· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining optimum hemoglobin sampling for anemia management from every-treatment data.
Adam E Gaweda, Brian H Nathanson, Alfred A Jacobs, George R Aronoff, Michael J Germain

Clin J Am Soc Nephrol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of model predictive control for improved anemia management.
Michael E Brier, Adam E Gaweda, Andrew Dailey, George R Aronoff, Alfred A Jacobs

Clin J Am Soc Nephrol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.
Adam E Gaweda, Linda J Goldsmith, Michael E Brier, George R Aronoff

Clin J Am Soc Nephrol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis